Showing 1 - 20 results of 262,905 for search '(((( 12 mm decrease ) OR ( 10 ((_ decrease) OR (a decrease)) ))) OR ( 5 ng decrease ))*', query time: 1.66s Refine Results
  1. 1

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…[NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    MK-STYX decreases RhoA activation. by Brittany M. Flowers (670483)

    Published 2014
    “…<p>(<b>A</b>) PC12 cells were transfected with pMT2 or pMT2-FLAG-MK-STYX-FLAG. 24 hr post-transfection cells were stimulated with 100 ng/ml NGF, and lysed at the indicated time points. …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    TGF-β-mediated EMT decreases Dlg5 expression. by Takuhito Sezaki (169150)

    Published 2012
    “…The scale bar indicates 10 µm. TGF-β treatment induced EMT and decreased Dlg5 expression. …”
  20. 20

    Inhibition of the <i>Hedgehog</i> pathway leads to decreased ostegenesis <i>in vitro</i>. by Emily R. Nelson (247130)

    Published 2013
    “…<p>(A–B) qRT-PCR of e13.5 wild-type, CD-1 palate cultures treated with DMEM F12 +/− supplementation with cyclopamine (20 mM) or Shh-N (250 ng/mL) for 2 days. …”